Physician profile
John Pearce
NPI 1710979547
$1,112.80
in general payments reported to CMS, 2019-2025
20 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $312 · 2021: $56.66 · 2022: $65.28 · 2023: $32.97 · 2024: $51.59 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $169.83 | 2019-2021 | |
| Depuy Synthes Sales INC. | $157.67 | 2019-2025 | Teligen |
| Zimmer Biomet Holdings, INC. | $123.92 | 2019 | |
| Pacira Therapeutics, INC. | $114.48 | 2020 | |
| Abbott Laboratories | $91.40 | 2022-2025 | Eterna |
| Djo, LLC | $53.70 | 2020 | |
| Heraeus Medical, LLC. | $48.45 | 2019-2020 | |
| Bioventus LLC | $45.15 | 2019-2020 | |
| Orthofix Medical, INC. | $44.99 | 2019-2020 | |
| Horizon Therapeutics Plc | $41.38 | 2020 | |
| Medtronic, INC. | $39.26 | 2024 | Intellis Adaptivestim |
| Ferring Pharmaceuticals INC. | $32.17 | 2019-2023 | Euflexxa |
| Melinta Therapeutics, LLC | $29.00 | 2019 | |
| Kerecis Limited | $24.39 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.29 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Bct, INC. | $18.94 | 2019 | |
| Innovation Technologies INC | $16.24 | 2023 | Irrisept |
| Smith+Nephew, INC. | $15.55 | 2022 | |
| Ermi LLC | $12.33 | 2024 | |
| Arteriocyte Medical Systems, INC. | $10.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.